Dantrium (Dantrolene Capsules) and Omalizumab Subcutaneous
Determining the interaction of Dantrium (Dantrolene Capsules) and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dantrolene
Brand name: Dantrium, Dantrium Intravenous, Revonto, Ryanodex
Synonyms: Dantrium
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dantrium (Dantrolene Capsules)-Ombitasvir, Paritaprevir, and Ritonavir
- Dantrium (Dantrolene Capsules)-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Dantrium (Dantrolene Capsules)-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Dantrium (Dantrolene Capsules)-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Dantrium (Dantrolene Capsules)-Omeclamox-Pak
- Dantrium (Dantrolene Capsules)-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Dantrium (Dantrolene Injection)
- Omalizumab Subcutaneous-Dantrium Intravenous
- Omalizumab Subcutaneous-Dantrolene
- Omalizumab Subcutaneous-Dantrolene Capsules
- Omalizumab Subcutaneous-Dantrolene Injection
- Omalizumab Subcutaneous-Dantrolene Intravenous